Covidien’s DuraSeal Spine Sealant Receives FDA Approval

The FDA has approved marketing of Covidien’s DuraSeal spine sealant as an adjunct to suturing for intra-operative dural sealing in spine procedures, according to a release from Covidien.

Advertisement

The Mansfield, Mass.-based company says DuraSeal is designed to be a quicker solution than conventional sealing methods for surgeons who are faced with a dural tear.

The FDA approved the same formulation in 2005 for cranial procedures.

Read Covidien’s release on the FDA approval of DuraSeal spine sealant.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.